P19-48. Induction of Ad5 neutralizing antibodies in placebo recipients during the Step Trial is not associated with risk of HIV infection

[...] there was no evidence of an association between HIV infection and increases in Ad5 titers in participants. [...] post-enrolment Ad5 infection is not a predisposing factor for HIV acquisition in the placebo group of the Step Trial.

Saved in:
Bibliographic Details
Published inRetrovirology Vol. 6; no. Suppl 3; p. P368
Main Authors Spies, G, Simandl, J, Casimiro, D, DeFawe, O, Noonan, L, Frahm, N, McElrath, MJ
Format Journal Article
LanguageEnglish
Published London BioMed Central 22.10.2009
BioMed Central Ltd
BMC
Subjects
Acquired immune deficiency syndrome
AIDS
HIV
Human immunodeficiency virus
Medical research
Poster Presentation
Vaccines
Online AccessGet full text

Cover

More Information
Summary:[...] there was no evidence of an association between HIV infection and increases in Ad5 titers in participants. [...] post-enrolment Ad5 infection is not a predisposing factor for HIV acquisition in the placebo group of the Step Trial.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1742-4690
1742-4690
DOI:10.1186/1742-4690-6-S3-P368